Physician profile
Stephen W Commiskey
NPI 1003014606
$1,264.87
in general payments reported to CMS, 2019-2025
20 companies · $80.58 in 2025
The $80.58 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $249 · 2021: $175 · 2022: $228 · 2023: $68.69 · 2024: $170 · 2025: $80.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $199.74 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2020 | |
| Ucb, INC. | $125.00 | 2019 | |
| Genentech USA, INC. | $123.12 | 2019 | |
| Merck Sharp & Dohme LLC | $112.81 | 2019-2024 | Bridion |
| Neurelis, INC. | $109.86 | 2020 | |
| Acadia Pharmaceuticals INC | $107.89 | 2023-2025 | Nuplazid |
| Sk Life Science, INC. | $89.87 | 2021 | |
| Jazz Pharmaceuticals INC. | $64.79 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.54 | 2023-2025 | Hyqvia |
| Amgen INC. | $21.63 | 2022 | |
| Chiesi USA, INC. | $20.68 | 2019 | |
| Acacia Pharma INC | $17.59 | 2022 | |
| Janssen Biotech, INC. | $17.09 | 2025 | |
| Lilly USA, LLC | $16.98 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $16.65 | 2021 | |
| Biogen, INC. | $16.56 | 2024 | Skyclarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.05 | 2025 | Caplyta |
| Hologic Sales and Service, LLC | $11.67 | 2019 | |
| Greenwich Biosciences, INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Commiskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.